{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:45:45Z","timestamp":1788561945066,"version":"build-2803163510"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201812140"],"award-info":[{"award-number":["tsqn201812140"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115704","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:24:19Z","timestamp":1760804659000},"page":"115704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Taming the immune storm: The pivotal role of tolerogenic dendritic cells in the pathogenesis and treatment of immune thrombocytopenia"],"prefix":"10.1016","volume":"167","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115704_bb0005","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fimmu.2019.01325","article-title":"Costimulatory molecules and immune checkpoints are differentially expressed on different subsets of dendritic cells","volume":"10","author":"Carenza","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2018.00274","article-title":"Tolerogenic dendritic cells in solid organ transplantation: where do we stand?","volume":"9","author":"Mar\u00edn","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fimmu.2020.00340","article-title":"Enhanced phenotype definition for precision isolation of precursor exhausted tumor-infiltrating CD8 T cells","volume":"11","author":"Martinez-Usatorre","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fimmu.2020.00674","article-title":"Tolerizing strategies for the treatment of autoimmune diseases: from ex vivo to in vivo strategies","volume":"11","author":"Cauwels","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4049\/jimmunol.1900970","article-title":"Merocytic dendritic cells compose a conventional dendritic cell subset with low metabolic activity","volume":"205","author":"Audiger","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2015.00288","article-title":"The role of dendritic cell subsets and innate immunity in the pathogenesis of type 1 diabetes and other autoimmune diseases","volume":"6","author":"Price","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcdb.2018.02.018","article-title":"Human in vivo-differentiated monocyte-derived dendritic cells","volume":"86","author":"Tang-Huau","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by Tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115704_bb0050","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3389\/fimmu.2018.02590","article-title":"Contribution of dendritic cell responses to Sepsis-induced immunosuppression and to susceptibility to secondary pneumonia","volume":"9","author":"Bouras","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115704_bb0055","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3390\/cancers11101557","article-title":"Exosomes: versatile Nano mediators of immune regulation","volume":"11","author":"Li","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00281-016-0587-8","article-title":"Tolerogenic dendritic cells","volume":"39","author":"Takenaka","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"21","key":"10.1016\/j.intimp.2025.115704_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178949","article-title":"Targeting aryl hydrocarbon receptor functionally restores Tolerogenic dendritic cells derived from patients with multiple sclerosis","volume":"134","author":"Fondelli","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2025.115704_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151929","article-title":"Quercetin induces an Immunoregulatory phenotype in maturing human dendritic cells","volume":"225","author":"Michalski","year":"2020","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0075","article-title":"The tumor microenvironment and dendritic cells: developers of pioneering strategies in colorectal Cancer immunotherapy?. Biochimica et Biophysica Acta. Reviews on","volume":"1880","author":"Ghorbaninezhad","year":"2025","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.115704_bb0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41423-018-0005-3","article-title":"Chemokine and chemotactic signals in dendritic cell migration","volume":"15","author":"Tiberio","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cns.12342","article-title":"Beneficial effect of Tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis","volume":"21","author":"Mansilla","year":"2015","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2025.115704_bb0090","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2174\/1389203719666180608093913","article-title":"ICOS-L as a potential therapeutic target for Cancer immunotherapy","volume":"19","author":"Marinelli","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"issue":"7528","key":"10.1016\/j.intimp.2025.115704_bb0095","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115704_bb0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fimmu.2019.00630","article-title":"PD-1 primarily targets TCR signal in the inhibition of functional T cell activation","volume":"10","author":"Mizuno","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0105","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1002\/jcp.27422","article-title":"Preventative tracheal Administration of Interleukin-27 attenuates allergic asthma by improving the lung Th1 microenvironment","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115704_bb0110","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/eji.201444999","article-title":"Development of Thymic Foxp3(+) regulatory T cells: TGF-\u03b2 matters","volume":"45","author":"Chen","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0115","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/eji.201445217","article-title":"Human Tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members","volume":"45","author":"Dixon","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0125","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4049\/jimmunol.2300442","article-title":"TDO2-overexpressed dendritic cells possess Tolerogenicity and ameliorate collagen-induced arthritis by modulating the Th17\/regulatory T cell balance","volume":"212","author":"Jia","year":"2024","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0130","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood-2005-02-0494","article-title":"Heme Oxygenase-1 expression inhibits dendritic cell maturation and Proinflammatory function but conserves IL-10 expression","volume":"106","author":"Chauveau","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2025.115704_bb0135","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2019030236","article-title":"Tolerogenic dendritic cells attenuate experimental autoimmune Antimyeloperoxidase glomerulonephritis","volume":"30","author":"Odobasic","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1753425918821732","article-title":"Regulation of lung immunity by dendritic cells: implications for asthma, chronic obstructive pulmonary disease and infectious disease","volume":"25","author":"Peters","year":"2019","journal-title":"Innate Immun."},{"issue":"36","key":"10.1016\/j.intimp.2025.115704_bb0145","doi-asserted-by":"crossref","first-page":"E7536","DOI":"10.1073\/pnas.1706356114","article-title":"Foxp3-independent mechanism by which TGF-\u03b2 controls peripheral T cell tolerance","volume":"114","author":"Oh","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.115704_bb0150","doi-asserted-by":"crossref","first-page":"2636701","DOI":"10.1155\/2016\/2636701","article-title":"Metabolism is central to Tolerogenic dendritic cell function","volume":"2016","author":"Sim","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0155","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.celrep.2015.01.013","article-title":"Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways","volume":"10","author":"Ferreira","year":"2015","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1398-9995.2011.02776.x","article-title":"MicroRNA-23b promotes Tolerogenic properties of dendritic cells in vitro through inhibiting Notch1\/NF-\u03baB Signalling pathways","volume":"67","author":"Zheng","year":"2012","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/08820139.2019.1708385","article-title":"MiR-146a promotes Tolerogenic properties of dendritic cells and through targeting Notch1 signaling","volume":"49","author":"Tang","year":"2020","journal-title":"Immunol. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0170","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/febs.14292","article-title":"Nonapoptotic functions of Fas\/CD95 in the immune response","volume":"285","author":"Gu\u00e9gan","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.intimp.2025.115704_bb0175","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3389\/fimmu.2017.01279","article-title":"Clinical Tolerogenic dendritic cells: exploring therapeutic impact on human autoimmune disease","volume":"8","author":"Phillips","year":"2017","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.intimp.2025.115704_bb0180","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and Neuromyelitis Optica with peptide-loaded Tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"290","key":"10.1016\/j.intimp.2025.115704_bb0185","doi-asserted-by":"crossref","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous Tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S2213-8587(20)30104-2","article-title":"Safety and feasibility of intradermal injection with Tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes","volume":"8","author":"Nikolic","year":"2020","journal-title":"The Lancet. Diabetes & Endocrinology"},{"issue":"9","key":"10.1016\/j.intimp.2025.115704_bb0200","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous Tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.intimp.2025.115704_bb0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/cells8101291","article-title":"Current paradigms of Tolerogenic dendritic cells and clinical implications for systemic lupus erythematosus","volume":"8","author":"Ritprajak","year":"2019","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.intimp.2025.115704_bb0210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for refractory Crohn\u2019s disease: a phase I study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.intimp.2025.115704_bb0215","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/annrheumdis-2018-eular.2880","article-title":"SAT0212\u00a0the safety and tolerability of intra-articular injection of Tolerogenic dendritic cells in patients with rheumatoid arthritis: the preliminary results","volume":"77","author":"Kurochkina","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2025.115704_bb0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13063-025-08972-x","volume":"26","author":"Long","year":"2025","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.intimp.2025.115704_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030309","article-title":"Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and Intranodal cell administration","volume":"9","author":"Willekens","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43556-025-00300-8","article-title":"Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications","volume":"6","author":"Li","year":"2025","journal-title":"Molecular Biomedicine"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0235","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.advms.2022.09.001","article-title":"The modulatory role of dendritic cell-T cell cross-talk in breast Cancer: challenges and prospects","volume":"67","author":"Shahverdi","year":"2022","journal-title":"Adv. Med. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2025.115704_bb0240","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202401024","article-title":"AMPK activation induces RALDH+ Tolerogenic dendritic cells by rewiring glucose and lipid metabolism","volume":"223","author":"Brombacher","year":"2024","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0245","first-page":"770","article-title":"Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia","volume":"106","author":"Li","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0250","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.thromres.2014.11.042","article-title":"Imbalance between CD205 and CD80\/CD86 in dendritic cells in patients with immune thrombocytopenia","volume":"135","author":"Zhang","year":"2015","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00277-012-1556-5","article-title":"Decreased expression of Indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia","volume":"92","author":"Catani","year":"2013","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0260","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0039-1679909","article-title":"PD-1\/PD-L pathway potentially involved in ITP Immunopathogenesis","volume":"119","author":"Nie","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1074-7613(02)00398-9","article-title":"Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses","volume":"17","author":"MacLennan","year":"2002","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0609.2010.01534.x","article-title":"TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic Purpura","volume":"86","author":"Yu","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115704_bb0275","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.0802257","article-title":"Human B cell responses to TLR ligands are differentially modulated by myeloid and Plasmacytoid dendritic cells","volume":"182","author":"Douagi","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115704_bb0280","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/cbin.10268","article-title":"Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28\/CTLA-4 expression on regulatory T cells","volume":"38","author":"Yan","year":"2014","journal-title":"Cell Biol. Int."},{"issue":"8","key":"10.1016\/j.intimp.2025.115704_bb0285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41423-019-0324-z","article-title":"Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells","volume":"17","author":"Boldison","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0290","doi-asserted-by":"crossref","first-page":"1420205","DOI":"10.3389\/fimmu.2024.1420205","article-title":"The basic biology of NK cells and its application in tumor immunotherapy","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7444","key":"10.1016\/j.intimp.2025.115704_bb0295","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0300","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.20010934","article-title":"Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells","volume":"195","author":"Piccioli","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0305","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/cdd.2011.134","article-title":"HMGB1, an Alarmin promoting HIV dissemination and latency in dendritic cells","volume":"19","author":"Gougeon","year":"2012","journal-title":"Cell Death Differ."},{"issue":"24","key":"10.1016\/j.intimp.2025.115704_bb0310","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.3390\/ijms222413348","article-title":"The HLA-G immune checkpoint plays a pivotal role in the regulation of immune response in autoimmune diseases","volume":"22","author":"Zaborek-\u0141yczba","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115704_bb0315","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/eji.200940098","article-title":"Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo","volume":"40","author":"Persson","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115704_bb0320","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.1403161","article-title":"Regulatory dendritic cells restrain NK cell IFN-\u03b3 production through mechanisms involving NKp46, IL-10, and MHC class I-specific inhibitory receptors","volume":"195","author":"Spallanzani","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0325","first-page":"11","article-title":"IDO expression in Cancer: different compartment, different functionality?. Frontiers in immunology","author":"Meireson","year":"2020","journal-title":"Frontiers"},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/annrheumdis-2018-214024","article-title":"Tolerising cellular therapies: what is their promise for autoimmune disease?","volume":"78","author":"Mosanya","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"6\u20137","key":"10.1016\/j.intimp.2025.115704_bb0335","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/08820139.2012.676122","article-title":"Indoleamine 2,3-dioxygenase and dendritic cell Tolerogenicity","volume":"41","author":"Harden","year":"2012","journal-title":"Immunol. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0340","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/medicina58020211","article-title":"Immune thrombocytopenic Purpura as a hemorrhagic versus thrombotic disease: an updated insight into pathophysiological mechanisms","volume":"58","author":"T\u0103rniceriu","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0345","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cyto.2015.05.030","article-title":"GM-CSF: an immune modulatory cytokine that can suppress autoimmunity","volume":"75","author":"Bhattacharya","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2025.115704_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931316","article-title":"CTLA-4 silencing in dendritic cells loaded with colorectal Cancer cell lysate improves autologous T cell responses in vitro","volume":"13","author":"Ghorbaninezhad","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0355","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/mi.2008.66","article-title":"A focus on dendritic cells and macrophages as key regulators of mucosal immunity","volume":"1","author":"Kelsall","year":"2008","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115704_bb0360","first-page":"eaaz1580","article-title":"Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes. Science","volume":"6","author":"Han","year":"2020","journal-title":"Advances"},{"key":"10.1016\/j.intimp.2025.115704_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631285","article-title":"Inhibition of dendritic cell activation and modulation of T cell polarization by the platelet Secretome","volume":"12","author":"Saris","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0370","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2010-07-295477","article-title":"High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115704_bb0375","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1479-5876-11-128","article-title":"A short protocol using dexamethasone and Monophosphoryl lipid a generates Tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines","volume":"11","author":"Garc\u00eda-Gonz\u00e1lez","year":"2013","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115704_bb0380","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1189\/jlb.3A0714-334R","article-title":"MERTK as negative regulator of human T cell activation","volume":"97","author":"Cabez\u00f3n","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2008-04-154138","article-title":"Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2025.115704_bb0390","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/bloodadvances.2018026690","article-title":"Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia","volume":"3","author":"Wang","year":"2019","journal-title":"Blood Adv."},{"issue":"23","key":"10.1016\/j.intimp.2025.115704_bb0395","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1182\/bloodadvances.2020003887","article-title":"Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice","volume":"5","author":"Herd","year":"2021","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.intimp.2025.115704_bb0400","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2013-03-491555","article-title":"Thalidomide corrects impaired mesenchymal stem cell function in inducing Tolerogenic DCs in patients with immune thrombocytopenia","volume":"122","author":"Ma","year":"2013","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.intimp.2025.115704_bb0405","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1089\/scd.2017.0078","article-title":"Impaired function of bone marrow mesenchymal stem cells from immune thrombocytopenia patients in inducing regulatory dendritic cell differentiation through the Notch-1\/Jagged-1 signaling pathway","volume":"26","author":"Xu","year":"2017","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000517989","article-title":"The mechanistic effects and clinical applications of various derived mesenchymal stem cells in immune thrombocytopenia","volume":"145","author":"He","year":"2022","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0415","first-page":"ltad012","article-title":"Challenges in Tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration. Immunotherapy","volume":"3","author":"Mansilla","year":"2023","journal-title":"Advances"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0420","doi-asserted-by":"crossref","first-page":"15087","DOI":"10.1038\/s41598-017-15569-1","article-title":"Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"issue":"33","key":"10.1016\/j.intimp.2025.115704_bb0425","doi-asserted-by":"crossref","first-page":"52818","DOI":"10.18632\/oncotarget.10810","article-title":"Minocycline promotes the generation of dendritic cells with regulatory properties","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.intimp.2025.115704_bb0430","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3349\/ymj.2018.59.7.807","article-title":"Generation, characteristics and clinical trials of ex vivo generated Tolerogenic dendritic cells","volume":"59","author":"Kim","year":"2018","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0435","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/imm.12776","article-title":"1,25-Dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells","volume":"152","author":"Xie","year":"2017","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.intimp.2025.115704_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300142","article-title":"Regulation of dendritic cell functions by vitamins as promising therapeutic strategy for immune system disorders","volume":"7","author":"Ghahramanipour","year":"2023","journal-title":"Advanced Biology"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0445","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4049\/jimmunol.1600676","article-title":"Tolerogenic dendritic cells from poorly compensated type 1 diabetes patients have decreased ability to induce stable antigen-specific T cell Hyporesponsiveness and generation of suppressive regulatory T cells","volume":"198","author":"D\u00e1\u0148ov\u00e1","year":"2017","journal-title":"J. Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2025.115704_bb0450","doi-asserted-by":"crossref","first-page":"P11","DOI":"10.1186\/ar2237","article-title":"Generation of dexamethasone and vitamin D3-treated human monocyte-derived dendritic cells with Tolerogenic properties","volume":"9","author":"Sayers","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2025.115704_bb0455","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.it.2016.08.009","article-title":"mTOR-mediated regulation of dendritic cell differentiation and function","volume":"37","author":"Sukhbaatar","year":"2016","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0460","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2047-1440-1-16","article-title":"Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation","volume":"1","author":"Macedo","year":"2012","journal-title":"Transplantation Research"},{"key":"10.1016\/j.intimp.2025.115704_bb0465","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2018.01.014","article-title":"IFN-\u03b3 and tumor gangliosides: implications for the tumor microenvironment","volume":"325","author":"Dillinger","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0470","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115704_bb0475","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.4049\/jimmunol.1501769","article-title":"IL-10-modulated human dendritic cells for clinical use: identification of a stable and migratory subset with improved Tolerogenic activity","volume":"197","author":"Kryczanowsky","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0480","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-Generated Tolerogenic Dendritic Cells Are Optimal for Functional Regulatory T Cell Induction--a Comparative Study of Human Clinical-Applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clinical Immunology (Orlando, Fla.)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41423-019-0218-0","article-title":"Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10)","volume":"17","author":"Comi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0490","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fimmu.2018.00350","article-title":"Mechanisms of tolerance induction by dendritic cells in vivo","volume":"9","author":"Hasegawa","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115704_bb0495","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4049\/jimmunol.1502615","article-title":"Tolerogenic phenotype of IFN-\u03b3-induced IDO+ dendritic cells is maintained via an autocrine IDO-kynurenine\/AhR-IDO loop","volume":"197","author":"Li","year":"2016","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115704_bb0500","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","article-title":"Regulatory T Cells Induced by 1 Alpha,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance","volume":"167","author":"Gregori","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0505","doi-asserted-by":"crossref","first-page":"3067126","DOI":"10.1155\/2018\/3067126","article-title":"Impact of retinoic acid on immune cells and inflammatory diseases","volume":"2018","author":"de Oliveira","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2025.115704_bb0510","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-011-8255-5","article-title":"Generation of immunogenic and Tolerogenic clinical-grade dendritic cells","volume":"51","author":"Kalantari","year":"2011","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0515","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/ol.2020.12351","article-title":"Myeloid and Plasmacytoid dendritic cell combined vaccines loaded with heat-treated tumor cell lysates enhance antitumor activity in murine lung Cancer","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2025.115704_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122265","article-title":"Immunomodulation by subcutaneously injected Methacrylic acid-based hydrogels and Tolerogenic dendritic cells in a mouse model of autoimmune diabetes","volume":"301","author":"Kinney","year":"2023","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0525","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2013.09.008","article-title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?","volume":"13","author":"Van Brussel","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0530","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2003-07-2412","article-title":"Cyclosporin a impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting Cyclooxygenase-2 expression","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2013.04.001","article-title":"Tolerogenic dendritic cells generated with IL-10\/TGF\u03b21 relieve immune thrombocytopenia in mice","volume":"132","author":"Zhang","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2025.115704_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103051","article-title":"Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases","volume":"138","author":"Passeri","year":"2023","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0545","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic dendritic cells in autoimmunity and inflammatory diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115704_bb0550","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s40265-021-01553-7","article-title":"Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists","volume":"81","author":"Gilreath","year":"2021","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.intimp.2025.115704_bb0555","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/BOR.0b013e32835cb9f2","article-title":"Dendritic cell vaccination in autoimmune disease","volume":"25","author":"Gross","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115704_bb0560","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14656566.2022.2082283","article-title":"Evaluating Fostamatinib disodium as a treatment option for immune thrombocytopenia in adult patients","volume":"23","author":"Dierickx","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.intimp.2025.115704_bb0565","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00228-020-02960-7","article-title":"Evaluation of drug-drug interaction of Lusutrombopag, a Thrombopoietin receptor agonist, via metabolic enzymes and transporters","volume":"76","author":"Katsube","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115704_bb0570","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","article-title":"Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia","volume":"19","author":"Hou","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115704_bb0575","article-title":"A simple and efficient method for testing immunomodulatory agents for generation of Tolerogenic dendritic cells from human CD14+ monocytes","volume":"218","author":"Jia","year":"2025","journal-title":"Journal of Visualized Experiments: JoVE"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/10547738241291272","article-title":"Management of Glucocorticoid-Induced Hyperglycemia in Cancer patients: a feasibility study","volume":"34","author":"Wright","year":"2025","journal-title":"Clin. Nurs. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0585","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12964-024-01641-7","article-title":"Emerging strategies for treating autoimmune disease with genetically modified dendritic cells","volume":"22","author":"Ma","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2025.115704_bb0590","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2018.07.005","article-title":"Nrf2-mediated metabolic reprogramming of Tolerogenic dendritic cells is protective against aplastic Anemia","volume":"94","author":"Wei","year":"2018","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0595","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.immuni.2017.06.021","article-title":"Local modulation of antigen-presenting cell development after resolution of pneumonia induces Long-term susceptibility to secondary infections","volume":"47","author":"Roquilly","year":"2017","journal-title":"Immunity, Elsevier"},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0600","article-title":"The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance","volume":"2011","author":"Janikashvili","year":"2011","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115704_bb0605","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in Cancer: from bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"46","key":"10.1016\/j.intimp.2025.115704_bb0610","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.intimp.2025.115704_bb0615","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000512451","article-title":"Recent advances in good manufacturing practice-grade generation of dendritic cells","volume":"47","author":"Cunningham","year":"2020","journal-title":"Transfus. Med. Hemother."},{"issue":"11","key":"10.1016\/j.intimp.2025.115704_bb0620","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcyt.2019.09.001","article-title":"Automated good manufacturing practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-Fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for Cancer vaccines","volume":"21","author":"Uslu","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.intimp.2025.115704_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:37:14Z","timestamp":1765456634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925016959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":125,"alternative-id":["S1567576925016959"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115704","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taming the immune storm: The pivotal role of tolerogenic dendritic cells in the pathogenesis and treatment of immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115704"}}